Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Au nanostructures by colloidal lithography: from quenching to extensive fluorescence enhancement.

Journal of materials chemistry. B·2020
Same author

PEEK Composites as Self-Lubricating Bush Materials for Articulating Revolute Pin Joints.

Polymers·2020
Same author

Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer.

Journal of Cancer·2020
Same author

Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils.

International journal of molecular sciences·2020
Same author

Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT.

Nuclear medicine and biology·2020
Same author

Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study.

Neuroscience letters·2020
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
See all related articles

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

Biomarkers.

Xinyi Lyu1, Feng Gao2, Xiaodong Pan3

  • 1Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
PubMed
Summary
This summary is machine-generated.

This study compares blood biomarkers for Alzheimer's disease (AD) detection in China, evaluating their accuracy against PET scans. Findings will help optimize early AD screening using reliable blood tests.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

Area of Science:

  • Neurology
  • Biomarker Discovery
  • Medical Diagnostics

Background:

  • Alzheimer's disease (AD) diagnosis relies on invasive methods, with blood biomarkers showing promise but lacking standardized detection.
  • Inconsistencies in current blood biomarker detection hinder widespread clinical application for AD screening and diagnosis.

Purpose of the Study:

  • To conduct a head-to-head comparison of commercially available blood biomarkers for Alzheimer's disease (AD) detection.
  • To assess the sensitivity and specificity of plasma biomarkers (Aβ40, Aβ42, t-tau, p-tau) in predicting amyloid pathology confirmed by Aβ-PET.
  • To optimize the clinical pathway for AD screening and diagnosis in the Chinese population.

Main Methods:

  • The CLEAR-AD study is a cross-sectional study in China involving 400 participants across different cognitive statuses (cognitively normal, MCI, dementia).
  • Participants undergo amyloid Positron Emission Tomography (Aβ-PET) scans.
  • Plasma biomarkers are measured using various detection methods (e.g., single-molecule immunoassay, digital immunoassay chips) under blinded conditions and compared against Aβ-PET results.

Main Results:

  • The study evaluates the diagnostic accuracy of plasma biomarkers against Aβ-PET as the reference standard.
  • Receiver operating characteristic (ROC) curves are generated to determine optimal cut-off values for biomarker detection.
  • A predictive model integrating multiple biomarkers and clinical data is developed to enhance diagnostic capabilities.

Conclusions:

  • The CLEAR-AD study provides essential data on the performance of commercial blood biomarkers for predicting Alzheimer's disease (AD) amyloid pathology.
  • Findings will inform the optimization of early AD screening strategies, particularly within the Chinese population.
  • The results are expected to guide the development of more effective diagnostic tools for AD.